The Compounding Tortoise

The Compounding Tortoise

Share this post

The Compounding Tortoise
The Compounding Tortoise
The Magic Formula to Keep Compounding Amidst Slowing Growth

The Magic Formula to Keep Compounding Amidst Slowing Growth

+ recapping the recent earnings reports, and determining the total consideration paid for M&A

The Compounding Tortoise's avatar
The Compounding Tortoise
Oct 25, 2024
∙ Paid
7

Share this post

The Compounding Tortoise
The Compounding Tortoise
The Magic Formula to Keep Compounding Amidst Slowing Growth
3
Share

Welcome to another bi-weekly digest to stay informed about everything that matters most to quality growth investors!

The goal of these digests:

  • to elaborate on premium members’ questions (you’ve provided some great inspiration for future posts and deep dives, thanks for that!);

  • to have a high-level discussion on some macro events;

  • to elaborate on some fundamental topics;

  • to talk about portfolio strategy;

  • to highlight a research piece that may be of interest to our members;

In case you’ve missed our previous articles/webinars/earnings recaps/deep dives:

  1. It's Buy-and-Monitor, Not Buy-and-Hold

  2. Key Lessons from Chuck Akre

  3. Letter to Our Partners - Q3 2024

+ much more on earnings reviews, fundamentals analysis

Q3 Earnings Season - Much Ado About Nothing?

Q3 Earnings Season - Much Ado About Nothing?

The CT
·
October 21, 2024
Read full story

In this digest, we will discuss strategies for enhancing the odds of success in a long-term investment portfolio, particularly in light of potentially more muted earnings growth for many companies.

Additionally, we will address a question from one of our premium members regarding the total consideration paid for acquisitions given the existence of deferred payments.

Upfront: always great insights, thank you! I would really appreciate if you could once walk us through one of this purchase price agreements in one of your bi-weekly webinars. How to analyse them and what to watch out for? In my ignorance, I often skip them too quickly, mainly because I might not understand all moving parts in it. And if you could also elaborate on the rise of options in M&A for these serial acquirers to cover all contingencies or purchase deferals, and what are their impact for our analysis. It would help me tremendously - thanks in advance!

Lastly, we’ll share some third-party research on a moat’s longevity.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 The Compounding Tortoise
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share